Antares Pharma reported $764K in Interest Expense on Debt for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Abbott ABT:US $ 106M 25M
Aerie Pharmaceuticals AERI:US $ 1.64M 0M
Becton, Dickinson and BDX:US $ 99M 2M
Eli Lilly And LLY:US $ 81.2M 3.7M
Pacira Pharmaceuticals PCRX:US $ 8.83M 1.41M
Pfizer PFE:US $ 293M 29M
Revance Therapeutics RVNC:US $ 3.87M 1.94M
Sientra SIEN:US 2.32M 426K
Supernus Pharmaceuticals SUPN:US $ 1.81M 0.66M
Teva Pharmaceutical TEVA:IT 225M 13M
Teva Pharmaceutical Industries TEVA:US $ 225M 13M